Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associate Professor at the University of Toronto.  She has been involved with the development of the Diabetes Canada clinical practice guidelines since 2 003 and served as Chair for the 2013 version. In recognition of her contribution, she has received the national Charles H. Best Award and the Gerald S. Wong Service Award from Diabetes Canada.  She is also the creator of The Med Ed Pledge – an initiative to increase Diversity & Inclusion in continuing medical education (www.theMedEdPledge.com).

Dr. Cheng discloses sources of funding and relationships with the following commercial stakeholders in the healthcare sector:  Advisory board or speaking honoraria from:  Abbott, Astra Zeneca, Bausch, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly, HLS Therapeutics, Insulet, Janssen, Medtronic, Novo Nordisk, Sanofi, Takeda.